Skip to content

Innovative Spinopelvic Solutions with Real-World Evidence

Innovative Spinopelvic Solutions with Real-world Evidence

Status
Enrolling by invitation
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06706908
Acronym
INSPIRE
Enrollment
1000
Registered
2024-11-27
Start date
2024-12-15
Completion date
2034-12-31
Last updated
2024-12-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Sacroiliac Joint Dysfunction, Sacroiliac Joint Pain

Brief summary

INSPIRE is a prospective decentralized study evaluating post-operative health outcomes in patients who undergo a procedure using implants manufactured by SI-BONE.

Interventions

Participants are expected to complete a series of health questionnaires (i.e. numerical rating scale, Oswestry Disability Index) relevant to their treatment using a SI-BONE implant.

Sponsors

SI-BONE, Inc.
Lead SponsorINDUSTRY

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
21 Years to No maximum
Healthy volunteers
No

Inclusion criteria

1. Age \> 21 at time of screening. 2. Patient will undergo a procedure utilizing an iFuse Implant family product. 3. Patient is comfortable communicating in written and spoken English. 4. Patient is willing and able to complete study questionnaires online, using either a smartphone, tablet, or computer. 5. Patient is willing and able to provide informed consent to participate

Exclusion criteria

1. Patient has fibromyalgia. 2. Patient has a pain pump. 3. Patient is currently receiving or seeking worker's compensation, disability remuneration, and/or involved in injury litigation

Design outcomes

Primary

MeasureTime frameDescription
Change in patient reported outcomesFrom enrollment and at the following timepoints, 1-, 3-, 6-, and 12-months.Change in pain as rated on a numerical rating scale (NRS), 0 being no pain and 10 being the worst pain imaginable at baseline and follow-up timepoints.

Secondary

MeasureTime frameDescription
Change in patient reported outcomesAt the following timepoints: 1-, 3-, 6-, and 12-months.Change in patient satisfaction on a four point scale, with 0 being very dissatisfied and 3 being very satisfied at follow-up timepoints.

Other

MeasureTime frameDescription
Postoperative incidence of:At the following timepoints, 1-, 3-, 6-, and 12-months.* Serious adverse events probably or definitely related to the implant of interest * Implant failures related to the implant of interest (e.g., revision surgery)

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026